ข่าวประชาสัมพันธ์ Merck KGaA

Merck KGaA, Darmstadt, Germany and p-Chip Corporation Collaborate to Improve Trust and Transparency in Machine-to-Machine Driven Industrial Value Chains

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and p-Chip Corporation, a company that is revolutionizing the tracking of physical products and materials with its breakthrough microtransponder technology, today announced the conclusion of a joint development agreement to develop and implement a new solution that offers never-before-seen levels of digital trust in machine-to-machine (M2M)-connected industrial value chains. "The processes and technologies that power

Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in Hard-to-Treat Cancers

- Not intended for UK-based media - Data to showcase Merck KGaA, Darmstadt, Germany's strong and diverse pipeline ranging from immuno-oncology to DNA damage response - Avelumab data...

Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual EUR 1 Million 'Grant for Oncology Innovation' Award

Not intended for UK-based media Grant established by Merck KGaA, Darmstadt, Germany, recognizes pioneering research in personalized treatment of solid tumors Winners selected by...

Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

Not intended for UK-based media ESMO Abstract # Avelumab: 777PD, 7775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP, 1292TiP Merck KGaA, Darmstadt, Germany, to...

Merck Millipore launched in Thailand, Advancing Life Science Together

Merck Thailand, the local subsidiary of a Germany based pharmaceutical and chemical company, formally introduced Merck Millipore to its customers in Thailand as part of its plan to expand the growth opportunities in the Life...

Mylan Completes Acquisition of Generics Business of Merck KGaA

Mylan (NYSE: MYL) announced today that it has completed its acquisition of Merck KGaA's generics business ("Merck Generics") to become one of the largest quality generics and specialty pharmaceuticals companies in the world. Mylan and...

Mylan Laboratories to Acquire Generics Business of Merck KGaA

Combination Creates a World Class Global Generics Leader Significant Scale and Breadth Will Drive Major Operating Efficiencies Highly Complementary Transaction Further Strengthens Mylan's Product Portfolio Accelerates Mylan's Revenue and...

Merck KGaA: Erbitux(R) (cetuximab) Continues to Deliver its Promise

Abstracts: 3085, 3509, 3535, 3549, 3555, 3556, 5537, 7109 Location: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO) 2006, Atlanta, Georgia Merck KGaA releases wealth of new Erbitux(R) (cetuximab) data at ASCO...